UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $82.42 Million Position in Teleflex Incorporated (NYSE:TFX)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 2.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 333,260 shares of the medical technology company’s stock after acquiring an additional 7,379 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Teleflex were worth $82,422,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of TFX. Cooke & Bieler LP raised its position in shares of Teleflex by 23.3% during the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock worth $191,989,000 after acquiring an additional 172,335 shares during the last quarter. TD Asset Management Inc raised its holdings in Teleflex by 12.0% during the 2nd quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company’s stock worth $95,928,000 after purchasing an additional 48,832 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Teleflex by 0.4% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock worth $105,749,000 after purchasing an additional 1,884 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Teleflex by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 425,647 shares of the medical technology company’s stock worth $89,526,000 after purchasing an additional 26,325 shares during the period. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Teleflex by 4.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 398,175 shares of the medical technology company’s stock valued at $83,741,000 after purchasing an additional 15,992 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on TFX. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Friday, November 1st. Mizuho lowered their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Royal Bank of Canada decreased their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Finally, Truist Financial restated a “hold” rating and set a $227.00 price target (down from $255.00) on shares of Teleflex in a report on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, Teleflex has an average rating of “Moderate Buy” and an average price target of $259.25.

Teleflex Stock Performance

Shares of TFX stock opened at $194.29 on Tuesday. Teleflex Incorporated has a 12 month low of $185.66 and a 12 month high of $257.85. The firm has a market capitalization of $9.02 billion, a PE ratio of 38.63, a price-to-earnings-growth ratio of 1.97 and a beta of 1.18. The firm has a fifty day simple moving average of $218.89 and a two-hundred day simple moving average of $222.26. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping the consensus estimate of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. During the same period in the previous year, the firm posted $3.64 earnings per share. The firm’s revenue for the quarter was up 2.4% on a year-over-year basis. Analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.70%. Teleflex’s payout ratio is 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.